content

Bachem reports excellent results for the first half-year 2021

Sales grow by 35.0% to CHF 239.1 million EBITDA rises from CHF 53.0 million to CHF 75.5 million and a margin of 31.6%. ...

Code Pharma BV: Antiviral Drug Codivir Shows Promising Effect Against COVID-19

Codivir, a short synthetic 16 amino-acid peptide, derived from the HIV-1 integrase, was originally discovered at the Hebrew University in Israel. Code Pharma discovered that...

Cryoport and Mitsubishi Logistics Corporation Partner to Bring Temperature-Controlled Supply Chain Solutions to Asia-Pacific

Cryoport, Inc., a leading global provider of innovative temperature-controlled supply chain solutions to the life sciences including clinical research, pharmaceutical and cell and gene...

Pfizer and BioNTech Announce Collaboration With Brazil’s Eurofarma to Manufacture COVID-19 Vaccine Doses for Latin America

Pfizer Inc. and BioNTech SE announced the signing of a letter of intent with Eurofarma Laboratรณrios SA, a Brazilian biopharmaceutical company, to manufacture COMIRNATY...

NRx’s Zyesami lowers respiratory distress in Phase IIb/III Covid-19 trial

NRx Pharmaceuticals has reported additional data from Phase IIb/III clinical trial where its drug, Zyesami (aviptadil), offered a rise in blood oxygen within a...

Virpax Inks MMS019 Manufacturing and Supply Agreement

Virpax Pharmaceuticals, a company specializing in developing product candidates for pain management, CNS and anti-viral indications, has entered into a commercial manufacturing and supply...

Cipla and Kemwell Biopharma announce execution of a joint venture agreement for developing, manufacturing and commercialising biosimilars

Cipla Limited, a leading global pharmaceutical company and Kemwell Biopharma Private Limited, a leading biopharmaceutical Contract Development and Manufacturing Organisation (CDMO), announced execution of...

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from up to 5 devices at once

Must read